Top Markets
Coin of the day
Mega Genomics Limited Mega Genomics Limited

Mega Genomics Limited

6667
株式のランク #18329
Mega Genomics Limited, a genetic testing platform company, offers consumer... Mega Genomics Limited, a genetic testing platform company, offers consumer genetic testing and cancer screening services in China. It offers brain health assessment package, a service that assesses the risk of various related diseases, including Alzheimer’s disease; alimentation capability assessment package, a service that assesses the risk of developing hyperhomocysteinemia; Parkinson’s disease risk assessment; full-scale cancer risk assessment packages; myocardial infarction and heart failure genetic testing, a service and ancillary service that assesses the genetic risk of developing myocardial infarction and heart failure; cardiovascular and cerebrovascular disease risk assessment packages; hereditary breast cancer/ovarian cancer genetic testing; Septin9 colorectal cancer screening test; RNF180/Septin9 gastric cancer screening test; cervical cancer genetic methylation testing, a cervical cancer test; telomere length genetic testing that assesses the cell age and aging rate of a person; and personal whole genome test plus, a service that assesses the risk of developing multiple types of diseases and provides interpretation for various individual traits and medication advice. It also offers whole exome sequencing package for adults, a service that assesses the risk of developing multiple high-risk diseases, hereditary cancers, recessive genetic diseases, and types of complex diseases, as well as multiple drugs, dietary nutrition items, and exercise and fitness items; folate metabolic capacity assessment testing kits to assess the risk of developing cardiovascular and cerebrovascular diseases; ApoE gene testing for testing Alzheimer’s disease; BRCA1/2 gene mutation testing kits; Alzheimer’s disease screening kits; colorectal cancer screening kits; gastric cancer screening kits; lung nodule auxiliary diagnostic kits; and cervical cancer screening kits to health checkup centers and hospitals. The company was founded in 2016 and is headquartered in Beijing, China.
株価
$0.90571771
時価総額
$203.15M
変化(1日)
0.07%
変化(1年)
-1.87%
CN
取引 Mega Genomics Limited (6667)

カテゴリー

Mega Genomics Limited(6667)の株価履歴
終値の最高値: $0.91 (2026-09-01)

終値の最安値: $2.28 (2022-06-01)
Mega Genomics Limited の株価履歴(2022 ~ 2026)
年間株価パフォーマンス
パフォーマンス
2026 (TTM) -1.68%
2025 -10.10%
2024 -1.39%
2023 -40.42%
2022 0.00%
類似企業または競合の株価
企業 株価 変化率 1年%
$402.90 -1.16%
US
$52.89 -2.50%
DE
$61.54 -4.62%
SA
$258.96 38.55%
US
$2.04 25.10%
MY